Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-gamma-lactones as protein kinase C ligands and antitumor agents

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1008-12. doi: 10.1016/j.bmcl.2009.12.058. Epub 2009 Dec 21.

Abstract

A series of DAG-lactones with polar 3-alkylidene substituents have been investigated as PKC-alpha ligands and antitumor agents. Extensive analysis of structure-activity relationships for the 3-alkylidene chain revealed that polar groups such as ether, hydroxyl, aldehyde, ester, acyloxy, and amido were tolerated with similar binding affinities and reduced lipophilicities compared to the corresponding unsubstituted alkylidene chain. Among the derivatives, compounds 5, 6 and 8 with an ether type of side chain showed high binding affinities in range of K(i)= 3-5 nM and excellent antitumor profiles, particularly against the colo205 colon cancer and the K562 leukemia cell lines.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / chemistry
  • 4-Butyrolactone / metabolism
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / metabolism*
  • HL-60 Cells
  • Humans
  • K562 Cells
  • Lactones / chemistry
  • Lactones / metabolism
  • Ligands
  • Protein Kinase C / metabolism*
  • Valerates / chemistry*
  • Valerates / metabolism*

Substances

  • (1-(hydroxymethyl)-4-(4-methyl-3-(methylethyl)pentylidene)-3-oxo-2-oxolanyl)methyl 4-methyl-3-(methylethyl)pentanoate
  • Antineoplastic Agents
  • Lactones
  • Ligands
  • Valerates
  • Protein Kinase C
  • 4-Butyrolactone